Shian‐Ren Lin

1.2k total citations · 1 hit paper
25 papers, 915 citations indexed

About

Shian‐Ren Lin is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shian‐Ren Lin has authored 25 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shian‐Ren Lin's work include Microbial Metabolism and Applications (6 papers), Prostate Cancer Treatment and Research (5 papers) and Tannin, Tannase and Anticancer Activities (4 papers). Shian‐Ren Lin is often cited by papers focused on Microbial Metabolism and Applications (6 papers), Prostate Cancer Treatment and Research (5 papers) and Tannin, Tannase and Anticancer Activities (4 papers). Shian‐Ren Lin collaborates with scholars based in Taiwan, China and United States. Shian‐Ren Lin's co-authors include Ching‐Feng Weng, Max K. Leong, Ping‐Jyun Sung, Henrich Cheng, May‐Jywan Tsai, Che‐Fang Hsu, Jian‐Chyi Chen, Yaw‐Syan Fu, Henrich Cheng and Yu‐Hsin Chen and has published in prestigious journals such as Oncogene, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Shian‐Ren Lin

25 papers receiving 908 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence

2019 304 citations Shian‐Ren Lin, Che‐Fang Hsu et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shian‐Ren Lin Taiwan	16	399	143	130	125	117	25	915
Jiao Zheng China	21	728 1.8×	169 1.2×	125 1.0×	159 1.3×	47 0.4×	79	1.4k
Aviral Kumar India	21	512 1.3×	100 0.7×	131 1.0×	70 0.6×	46 0.4×	43	1.1k
Jiaqing Cao China	24	852 2.1×	174 1.2×	128 1.0×	101 0.8×	157 1.3×	122	1.6k
Gwi Seo Hwang South Korea	24	702 1.8×	208 1.5×	73 0.6×	76 0.6×	78 0.7×	70	1.4k
Shiau‐Chuen Cheah Malaysia	19	460 1.2×	158 1.1×	198 1.5×	33 0.3×	189 1.6×	40	1.2k
Jiong Zhao United States	16	484 1.2×	199 1.4×	108 0.8×	107 0.9×	29 0.2×	25	952
Youn Kyung Choi South Korea	19	440 1.1×	152 1.1×	157 1.2×	33 0.3×	45 0.4×	36	957
Assunta Catalano Italy	18	502 1.3×	73 0.5×	83 0.6×	55 0.4×	63 0.5×	26	1.4k
Jagan M.R. Patlolla United States	19	796 2.0×	253 1.8×	228 1.8×	70 0.6×	101 0.9×	34	1.5k
Chung Ho Ryu South Korea	20	536 1.3×	140 1.0×	112 0.9×	35 0.3×	58 0.5×	32	1.0k

Countries citing papers authored by Shian‐Ren Lin

Since Specialization

Citations

This map shows the geographic impact of Shian‐Ren Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shian‐Ren Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shian‐Ren Lin more than expected).

Fields of papers citing papers by Shian‐Ren Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shian‐Ren Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shian‐Ren Lin. The network helps show where Shian‐Ren Lin may publish in the future.

Co-authorship network of co-authors of Shian‐Ren Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shian‐Ren Lin. A scholar is included among the top collaborators of Shian‐Ren Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shian‐Ren Lin. Shian‐Ren Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Chun‐Shu, Shian‐Ren Lin, Hui Long, et al.. (2022). Diterpene promptly executes a non-canonical autophagic cell death in doxorubicin-resistant lung cancer. Biomedicine & Pharmacotherapy. 153. 113443–113443. 4 indexed citations

Hung, Yi‐Ping, Shian‐Ren Lin, W. M. Lai, et al.. (2022). Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma. Frontiers in Medicine. 9. 1008855–1008855. 5 indexed citations

Lin, Shian‐Ren, et al.. (2021). Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ. Biomedicine & Pharmacotherapy. 144. 112333–112333. 22 indexed citations

Chen, Wei‐Yu, Yu-Ching Wen, Shian‐Ren Lin, et al.. (2021). Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance. Communications Biology. 4(1). 22–22. 38 indexed citations

Wen, Yu‐Ching, Yen‐Nien Liu, Hsiu‐Lien Yeh, et al.. (2021). TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer. Oncogenesis. 10(11). 81–81. 11 indexed citations

Lin, Shian‐Ren, Hsiu‐Lien Yeh, & Yen‐Nien Liu. (2021). Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation. Cancers. 13(14). 3452–3452. 10 indexed citations

Lin, Shian‐Ren, et al.. (2020). The production and bioactivity of prodigiosin: quo vadis?. Drug Discovery Today. 25(5). 828–836. 37 indexed citations

Lin, Shian‐Ren, et al.. (2020). Doxorubicin metabolism moderately attributes to putative toxicity in prodigiosin/doxorubicin synergism in vitro cells. Molecular and Cellular Biochemistry. 475(1-2). 119–126. 8 indexed citations

Lin, Shian‐Ren, Yu‐Ching Wen, Hsiu‐Lien Yeh, et al.. (2020). EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer. Oncogene. 39(44). 6757–6775. 33 indexed citations

10.

Lin, Shian‐Ren, Ntlotlang Mokgautsi, & Yen‐Nien Liu. (2020). Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis. Molecules. 25(10). 2380–2380. 22 indexed citations

11.

Lin, Shian‐Ren, et al.. (2019). Clerodane Diterpene Ameliorates Inflammatory Bowel Disease and Potentiates Cell Apoptosis of Colorectal Cancer. Biomolecules. 9(12). 762–762. 8 indexed citations

12.

Huang, Po-Kai, et al.. (2019). Natural phenolic compounds potentiate hypoglycemia via inhibition of Dipeptidyl peptidase IV. Scientific Reports. 9(1). 15585–15585. 46 indexed citations

13.

Huang, Po-Kai, et al.. (2019). Polyalthia Clerodane Diterpene Potentiates Hypoglycemia via Inhibition of Dipeptidyl Peptidase 4. International Journal of Molecular Sciences. 20(3). 530–530. 17 indexed citations

14.

Lin, Shian‐Ren, Che‐Fang Hsu, Henrich Cheng, et al.. (2019). Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. British Journal of Pharmacology. 177(6). 1409–1423. 304 indexed citations breakdown →

15.

Lin, Shian‐Ren, et al.. (2018). Hypoglycemic Efficacy of Docking Selected Natural Compounds against α-Glucosidase and α-Amylase. Molecules. 23(9). 2260–2260. 41 indexed citations

16.

Pham, Dinh‐Chuong, et al.. (2018). FAK and S6K1 Inhibitor, Neferine, Dually Induces Autophagy and Apoptosis in Human Neuroblastoma Cells. Molecules. 23(12). 3110–3110. 30 indexed citations

17.

Lin, Shian‐Ren, et al.. (2018). Prodigiosin-Emerged PI3K/Beclin-1-Independent Pathway Elicits Autophagic Cell Death in Doxorubicin-Sensitive and -Resistant Lung Cancer. Journal of Clinical Medicine. 7(10). 321–321. 30 indexed citations

18.

Lin, Shian‐Ren, Yaw‐Syan Fu, May‐Jywan Tsai, Henrich Cheng, & Ching‐Feng Weng. (2017). Natural Compounds from Herbs that can Potentially Execute as Autophagy Inducers for Cancer Therapy. International Journal of Molecular Sciences. 18(7). 1412–1412. 120 indexed citations

19.

Huang, Po-Kai, May‐Jywan Tsai, Max K. Leong, et al.. (2017). Encapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice. Nanomaterials. 7(5). 112–112. 30 indexed citations

20.

Cheng, Ming‐Fang, Chun‐Shu Lin, Yu‐Hsin Chen, et al.. (2017). Inhibitory Growth of Oral Squamous Cell Carcinoma Cancer via Bacterial Prodigiosin. Marine Drugs. 15(7). 224–224. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact